Add to ORKGA hepatitis B prevention and control programme has started in Singapore using BHepavac, an approved HB Vaccine manufactured for Singapore Biotech (Pte) by Merck Sharpe and Dohme (USA). 10 μg doses of the vaccine have been shown to be efficacious in populations under 40 years of age. In neonates, a smaller dose of 5 μg given three times at 0, 1, 2 months appears to be as effective as the 10 μg dose
Hepatitis B is a disease that affects people throughout the world, and over 200 million are persiste...
The national hepatitis B vaccination program in Taiwan is considered one of the most successful and ...
Hepatitis B virus is the commonest chronic viral pathogen affecting about 2 billion people worldwide...
A hepatitis B prevention and control programme has started in Singapore using BHepavac, an approved ...
In order to plan a strategy for control of hepatitis B virus infection in Malaysia, we determined (i...
In 2015, the World Health Organization (WHO) South-East Asia Region (SEAR)* reported an estimated 40...
Universal hepatitis B (HB) vaccination among Thai newborns was initiated in 1992. The first dose of ...
<div><p>Hepatitis B vaccination for newborns was introduced in two provinces in 1988 as part of Thai...
Universal hepatitis B (HB) vaccination among Thai newborns was initiated in 1992. The first dose of ...
Aim: A nationwide HBV vaccination for neonates in the Expanded Programme on Immunization (EPI) was i...
HBV infection is endemic in Singapore. The majority of infection is subclinical and infection occurs...
Hepatitis B vaccination for newborns was introduced in two provinces in 1988 as part of Thailand's E...
Background & Aims: Hepatitis B virus (HBV) infection was hyperendemic in Taiwan before the implement...
The world's first nationwide hepatitis B virus (HBV) universal vaccination program for infants was l...
Hepatitis B virus (HBV) infection is a global health threat; with 240 million people are chronic car...
Hepatitis B is a disease that affects people throughout the world, and over 200 million are persiste...
The national hepatitis B vaccination program in Taiwan is considered one of the most successful and ...
Hepatitis B virus is the commonest chronic viral pathogen affecting about 2 billion people worldwide...
A hepatitis B prevention and control programme has started in Singapore using BHepavac, an approved ...
In order to plan a strategy for control of hepatitis B virus infection in Malaysia, we determined (i...
In 2015, the World Health Organization (WHO) South-East Asia Region (SEAR)* reported an estimated 40...
Universal hepatitis B (HB) vaccination among Thai newborns was initiated in 1992. The first dose of ...
<div><p>Hepatitis B vaccination for newborns was introduced in two provinces in 1988 as part of Thai...
Universal hepatitis B (HB) vaccination among Thai newborns was initiated in 1992. The first dose of ...
Aim: A nationwide HBV vaccination for neonates in the Expanded Programme on Immunization (EPI) was i...
HBV infection is endemic in Singapore. The majority of infection is subclinical and infection occurs...
Hepatitis B vaccination for newborns was introduced in two provinces in 1988 as part of Thailand's E...
Background & Aims: Hepatitis B virus (HBV) infection was hyperendemic in Taiwan before the implement...
The world's first nationwide hepatitis B virus (HBV) universal vaccination program for infants was l...
Hepatitis B virus (HBV) infection is a global health threat; with 240 million people are chronic car...
Hepatitis B is a disease that affects people throughout the world, and over 200 million are persiste...
The national hepatitis B vaccination program in Taiwan is considered one of the most successful and ...
Hepatitis B virus is the commonest chronic viral pathogen affecting about 2 billion people worldwide...